How to buy McKesson stock in Canada

McKesson is a medical distribution business based in the US. McKesson shares (MCK) are listed on the NYSE and all prices are listed in US Dollars.

Its last market close was $570.98 – a decrease of 1.43% over the previous week. McKesson employs 45,000 staff and has a trailing 12-month revenue of around $330.2 billion.

Our top picks for where to buy McKesson Corporation stock

Buy McKesson Corporation stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

Finder Score for stock trading platforms

To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.

Read the full methodology

Related: Compare the best stock trading platforms in Canada

McKesson stock price (NYSE: MCK)

Use our graph to track the performance of MCK stocks over time.

McKesson stocks at a glance

• Key figures

Information last updated 2024-12-18.

Latest market close	$570.98
52-week range	$448.22 - $635.98
50-day moving average more info button	$564.44
200-day moving average more info button	$554.64
Wall St. target price	$653.95
PE ratio more info button	29.4928
Dividend yield more info button	$2.57 (0.5%)
Earnings per share (TTM) more info button	$19.36

Is it a good time to buy McKesson stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dive deeper: Our picks for the best stocks to buy right now in Canada

McKesson price performance over time

Historical closes compared with the close of $562.78 from 2024-12-17

1 week (2024-12-12)	-2.85%
1 month (2024-11-19)	-8.59%
3 months (2024-09-19)	10.75%
6 months (2024-06-18)	-6.66%

1 year (2023-12-19)	25.61%
2 years (2022-12-19)	51.43%
3 years (2021-12-17)	145.45%
5 years (2019-12-19)	330.23%

Is McKesson stock undervalued or overvalued?

Valuing McKesson stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of McKesson's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

McKesson's P/E ratio

McKesson's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 29x. In other words, McKesson shares trade at around 29x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the stock or simply that they're over-valued.

McKesson's PEG ratio

McKesson's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0492. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into McKesson's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.

McKesson's EBITDA

McKesson's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.9 billion.

The EBITDA is a measure of a McKesson's overall financial performance and is widely used to measure a its profitability.

McKesson financials

Revenue TTM	$330.2 billion
Operating margin TTM	0.8%
Gross profit TTM	$12.4 billion
Return on assets TTM	3.92%
Return on equity TTM	0%
Profit margin	0.77%
Book value	$-23.77
Market Capitalization more info button	$72.5 billion

TTM: trailing 12 months

McKesson stock dividends

Dividend payout ratio: 9.21% of net profits

Recently McKesson has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), McKesson shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In McKesson's case, that would currently equate to about $2.57 per share.

While McKesson's payout ratio might seem low, this can signify that McKesson is investing more in its future growth.

McKesson's most recent dividend payout was on 1 January 2025. The latest dividend was paid out to all shareholders who bought their stocks by 1 December 2024 (the "ex-dividend date").

Have McKesson's stocks ever split?

McKesson's stocks were split on a 2:1 basis on 4 January 1998 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your McKesson stocks – just the quantity. However, indirectly, the new 50% lower stock price could have impacted the market appetite for McKesson stocks, which in turn could have impacted McKesson's stock price.

McKesson stock price volatility

Over the last 12 months, McKesson's stocks have ranged in value from as little as $448.2217 up to $635.9769. A popular way to gauge a stock's volatility is its "beta."

Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while McKesson's is 0.436. This would suggest that McKesson's stocks are less volatile than average (for this exchange).

McKesson overview

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

Related: New to stock trading? Compare brokers and get tips for investing.

Frequently asked questions

What percentage of McKesson is owned by insiders or institutions?
Currently 0.099% of McKesson stocks are held by insiders and 89.079% by institutions. How many people work for McKesson?
Latest data suggests 45,000 work at McKesson. When does the fiscal year end for McKesson?
McKesson's fiscal year ends in March. Where is McKesson based?
McKesson's address is: 6555 State Highway 161, Irving, TX, United States, 75039 What is McKesson's ISIN number?
McKesson's international securities identification number is: US58155Q1031 What is McKesson's CUSIP number?
McKesson's Committee on Uniform Securities Identification Procedures number is: 581557105

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.